Pediatric idiopathic anaphylaxis: experience with 22 patients

J Allergy Clin Immunol. 1997 Sep;100(3):320-6. doi: 10.1016/s0091-6749(97)70244-6.

Abstract

Idiopathic anaphylaxis in the pediatric population is being increasingly recognized, with symptoms (and therefore classifications) the same as those described in adults. We present a series of 22 patients with special attention to considerations relatively unique to the pediatric population. Prednisone, hydroxyzine, and albuterol were used to control symptoms and induce remission. No deaths occurred during treatment. One adolescent who presented with corticosteroid-dependent idiopathic anaphylaxis was diagnosed with undifferentiated somatoform-idiopathic anaphylaxis. Local physician reluctance to participate in management complicated care for some patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenergic beta-Agonists / therapeutic use
  • Adult
  • Albuterol / therapeutic use
  • Anaphylaxis / diagnosis*
  • Anaphylaxis / drug therapy
  • Anaphylaxis / epidemiology
  • Anti-Inflammatory Agents / therapeutic use
  • Child
  • Delivery of Health Care
  • Diagnosis, Differential
  • Female
  • Histamine H1 Antagonists / therapeutic use
  • Humans
  • Hydroxyzine / therapeutic use
  • Male
  • Practice Patterns, Physicians'
  • Prednisone / therapeutic use

Substances

  • Adrenergic beta-Agonists
  • Anti-Inflammatory Agents
  • Histamine H1 Antagonists
  • Hydroxyzine
  • Albuterol
  • Prednisone